TTOO News and Press, T2 Biosystems Inc. From 03/12/24

LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listin...

2024-02-16 10:00:07 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...

2024-02-15 19:37:10 ET T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Conference Call February 15, 2024, 04:30 PM ET Company Participants Trip Taylor - IR John Sperzel - Chairman & CEO John Sprague - John Sprague Conference Call Participants Ben Hayn...

2024-02-15 16:12:27 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...

2024-02-15 16:10:32 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...

2024-02-15 16:09:25 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...

LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) --  T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for ...

LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the entrance into a definitive agreement to convert $15 million of its term loan with entities a...

LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of territory exclusive distribution agreements for new geographies in the Netherlands, B...

2024-02-12 12:12:31 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of T2 Biosystems (NASDAQ: TTOO ) are jumping higher by more than 30%. This comes as the diagnostics company announced that it had received U.S. Food and Drug Administration&#...